{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T12:14:35Z","timestamp":1791461675548,"version":"4.3.4"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T00:00:00Z","timestamp":1739232000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T00:00:00Z","timestamp":1739232000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Metab Brain Dis"],"DOI":"10.1007\/s11011-025-01552-7","type":"journal-article","created":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T09:30:28Z","timestamp":1739266228000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Unraveling the role of Nrf2 in dopaminergic neurons: a review of oxidative stress and mitochondrial dysfunction in Parkinson\u2019s disease"],"prefix":"10.1007","volume":"40","author":[{"given":"Manpreet","family":"Kaur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2450-2975","authenticated-orcid":false,"given":"Khadga Raj","family":"Aran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,11]]},"reference":[{"key":"1552_CR1","doi-asserted-by":"publisher","unstructured":"Ahmed SMU, Luo L, Namani A, Wang XJ, Tang X (2017) Nrf2 signaling pathway: pivotal roles in inflammation. Biochimica et Biophysica Acta (BBA)-Molecular basis of disease. 1863(2):585\u2013597. https:\/\/doi.org\/10.1016\/j.bbadis.2016.11.005","DOI":"10.1016\/j.bbadis.2016.11.005"},{"issue":"9","key":"1552_CR2","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.3390\/antiox11091780","volume":"11","author":"M Ahuja","year":"2022","unstructured":"Ahuja M, Kaidery NA, Dutta D, Attucks OC, Kazakov EH, Gazaryan I, Matsumoto M, Igarashi K, Sharma SM, Thomas B (2022) Harnessing the therapeutic potential of the Nrf2\/Bach1 signaling pathway in Parkinson\u2019s Disease. Antioxidants 11(9):1780. https:\/\/doi.org\/10.3390\/antiox11091780","journal-title":"Antioxidants"},{"issue":"6","key":"1552_CR3","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1001\/jama.2019.22360","volume":"323","author":"MJ Armstrong","year":"2020","unstructured":"Armstrong MJ, Okun MS (2020) Diagnosis and treatment of Parkinson disease: a review. JAMA 323(6):548\u2013560. https:\/\/doi.org\/10.1001\/jama.2019.22360","journal-title":"JAMA"},{"issue":"8","key":"1552_CR4","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1080\/1028415X.2021.1892985","volume":"25","author":"VK Arruri","year":"2022","unstructured":"Arruri VK, Gundu C, Kalvala AK, Sherkhane B, Khatri DK, Singh SB (2022) Carvacrol abates NLRP3 inflammasome activation by augmenting Keap1\/Nrf-2\/p62 directed autophagy and mitochondrial quality control in neuropathic pain. Nutr Neurosci 25(8):1731\u20131746. https:\/\/doi.org\/10.1080\/1028415X.2021.1892985","journal-title":"Nutr Neurosci"},{"key":"1552_CR5","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s40120-020-00220-5","volume":"10","author":"KL Au","year":"2021","unstructured":"Au KL, Wong JK, Tsuboi T, Eisinger RS, Moore K, Lemos Melo Lobo Jofili Lopes J, Holland MT, Holanda VM, Peng-Chen Z, Patterson A, Foote KD (2021) Globus Pallidus internus (GPi) deep brain stimulation for Parkinson\u2019s disease: expert review and commentary. Neurol Therapy 10:7\u201330. https:\/\/doi.org\/10.1007\/s40120-020-00220-5","journal-title":"Neurol Therapy"},{"key":"1552_CR6","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.brainres.2017.02.021","volume":"1662","author":"T Baluchnejadmojarad","year":"2017","unstructured":"Baluchnejadmojarad T, Rabiee N, Zabihnejad S, Roghani M (2017) Ellagic acid exerts protective effect in intrastriatal 6-hydroxydopamine rat model of Parkinson\u2019s disease: possible involvement of ER\u03b2\/Nrf2\/HO-1 signaling. Brain Res 1662:23\u201330. https:\/\/doi.org\/10.1016\/j.brainres.2017.02.021","journal-title":"Brain Res"},{"issue":"5","key":"1552_CR7","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1242\/dmm.007575","volume":"4","author":"MC Barone","year":"2011","unstructured":"Barone MC, Sykiotis GP, Bohmann D (2011) Genetic activation of Nrf2 signaling is sufficient to ameliorate neurodegenerative phenotypes in a Drosophila model of Parkinson\u2019s disease. Dis Models Mech 4(5):701\u2013707. https:\/\/doi.org\/10.1242\/dmm.007575","journal-title":"Dis Models Mech"},{"issue":"8","key":"1552_CR8","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1038\/s41418-023-01187-0","volume":"30","author":"P Bernardi","year":"2023","unstructured":"Bernardi P, Gerle C, Halestrap AP, Jonas EA, Karch J, Mnatsakanyan N, Pavlov E, Sheu SS, Soukas AA (2023) Identity, structure, and function of the mitochondrial permeability transition pore: controversies, consensus, recent advances, and future directions. Cell Death Differ 30(8):1869\u20131885. https:\/\/doi.org\/10.1038\/s41418-023-01187-0","journal-title":"Cell Death Differ"},{"issue":"11","key":"1552_CR9","doi-asserted-by":"publisher","first-page":"2849","DOI":"10.1021\/acschemneuro.8b00276","volume":"9","author":"A Biosa","year":"2018","unstructured":"Biosa A, Arduini I, Soriano ME, Giorgio V, Bernardi P, Bisaglia M, Bubacco L (2018) Dopamine oxidation products as mitochondrial endotoxins, a potential molecular mechanism for preferential neurodegeneration in Parkinson\u2019s disease. ACS Chem Neurosci 9(11):2849\u20132858. https:\/\/doi.org\/10.1021\/acschemneuro.8b00276","journal-title":"ACS Chem Neurosci"},{"key":"1552_CR10","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1111\/jnc.13731","volume":"139","author":"A Bose","year":"2016","unstructured":"Bose A, Beal MF (2016) Mitochondrial dysfunction in Parkinson\u2019s disease. J Neurochem 139:216\u2013231. https:\/\/doi.org\/10.1111\/jnc.13731","journal-title":"J Neurochem"},{"key":"1552_CR11","doi-asserted-by":"publisher","first-page":"175909141989978","DOI":"10.1177\/1759091419899782","volume":"12","author":"MS Brandes","year":"2020","unstructured":"Brandes MS, Gray NE (2020) NRF2 as a therapeutic target in neurodegenerative diseases. ASN Neuro 12:1759091419899782. https:\/\/doi.org\/10.1177\/1759091419899782","journal-title":"ASN Neuro"},{"issue":"8","key":"1552_CR12","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1089\/ars.2016.6800","volume":"27","author":"M Campolo","year":"2017","unstructured":"Campolo M, Casili G, Biundo F, Crupi R, Cordaro M, Cuzzocrea S, Esposito E (2017) The neuroprotective effect of dimethyl fumarate in an MPTP-mouse model of Parkinson\u2019s disease: involvement of reactive oxygen species\/nuclear factor-\u03baB\/nuclear transcription factor related to NF-E2. Antioxid Redox Signal 27(8):453\u2013471. https:\/\/doi.org\/10.1089\/ars.2016.6800","journal-title":"Antioxid Redox Signal"},{"key":"1552_CR13","unstructured":"Carbone C (2019) Ih loss of function as a pathogenic mechanism underlying the selective vulnerability of nigral dopamine neurons in Parkinson\u2019s disease. https:\/\/hdl.handle.net\/2158\/1155812"},{"key":"1552_CR14","doi-asserted-by":"publisher","first-page":"101118","DOI":"10.1016\/j.redox.2019.101118","volume":"22","author":"S Castro-S\u00e1nchez","year":"2019","unstructured":"Castro-S\u00e1nchez S, Garc\u00eda-Yag\u00fce \u00c1J, K\u00fcgler S, Lastres-Becker I (2019) CX3CR1-deficient microglia shows impaired signalling of the transcription factor NRF2: implications in tauopathies. Redox Biol 22:101118. https:\/\/doi.org\/10.1016\/j.redox.2019.101118","journal-title":"Redox Biol"},{"key":"1552_CR15","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1007\/s11064-018-2530-y","volume":"43","author":"Y Chandrasekhar","year":"2018","unstructured":"Chandrasekhar Y, Phani Kumar G, Ramya EM, Anilakumar KR (2018) Gallic acid protects 6-OHDA induced neurotoxicity by attenuating oxidative stress in human dopaminergic cell line. Neurochem Res 43:1150\u20131160. https:\/\/doi.org\/10.1007\/s11064-018-2530-y","journal-title":"Neurochem Res"},{"issue":"9","key":"1552_CR16","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1021\/tx300171u","volume":"25","author":"JH Chen","year":"2012","unstructured":"Chen JH, Ou HP, Lin CY, Lin FJ, Wu CR, Chang SW, Tsai CW (2012) Carnosic acid prevents 6-hydroxydopamine-induced cell death in SH-SY5Y cells via mediation of glutathione synthesis. Chem Res Toxicol 25(9):1893\u20131901. https:\/\/doi.org\/10.1021\/tx300171u","journal-title":"Chem Res Toxicol"},{"key":"1552_CR17","doi-asserted-by":"publisher","first-page":"113103","DOI":"10.1016\/j.ejmech.2020.113103","volume":"212","author":"JW Choi","year":"2021","unstructured":"Choi JW, Kim S, Yoo JS, Kim HJ, Kim HJ, Kim BE, Lee EH, Lee YS, Park JH, Park KD (2021) Development and optimization of halogenated vinyl sulfones as Nrf2 activators for the treatment of Parkinson\u2019s disease. Eur J Med Chem 212:113103. https:\/\/doi.org\/10.1016\/j.ejmech.2020.113103","journal-title":"Eur J Med Chem"},{"issue":"2","key":"1552_CR18","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.3892\/mmr.2015.4657","volume":"13","author":"Q Cui","year":"2016","unstructured":"Cui Q, Li X, Zhu H (2016) Curcumin ameliorates dopaminergic neuronal oxidative damage via activation of the Akt\/Nrf2 pathway. Mol Med Rep 13(2):1381\u20131388. https:\/\/doi.org\/10.3892\/mmr.2015.4657","journal-title":"Mol Med Rep"},{"issue":"4","key":"1552_CR19","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3233\/JPD-130230","volume":"3","author":"V Dias","year":"2013","unstructured":"Dias V, Junn E, Mouradian MM (2013) The role of oxidative stress in Parkinson\u2019s disease. J Parkinson\u2019s Disease 3(4):461\u2013491. https:\/\/doi.org\/10.3233\/JPD-130230","journal-title":"J Parkinson\u2019s Disease"},{"key":"1552_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12035-024-04526-5","volume":"27","author":"MC Epifane-de-Assun\u00e7\u00e3o","year":"2024","unstructured":"Epifane-de-Assun\u00e7\u00e3o MC, Bispo AG, Ribeiro-dos-Santos \u00c2, Cavalcante GC (2024) Molecular alterations in Core subunits of mitochondrial complex I and their relation to Parkinson\u2019s Disease. Mol Neurobiol Sep 27:1\u20135. https:\/\/doi.org\/10.1007\/s12035-024-04526-5","journal-title":"Mol Neurobiol Sep"},{"issue":"6","key":"1552_CR21","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1007\/s11306-024-02181-4","volume":"20","author":"X Flores-Ponce","year":"2024","unstructured":"Flores-Ponce X, Velasco I (2024) Dopaminergic neuron metabolism: relevance for understanding Parkinson\u2019s disease. Metabolomics 20(6):116. https:\/\/doi.org\/10.1007\/s11306-024-02181-4","journal-title":"Metabolomics"},{"key":"1552_CR22","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.fct.2020.111644","volume":"251","author":"HH Gaballah","year":"2016","unstructured":"Gaballah HH, Zakaria SS, Elbatsh MM, Tahoon NM (2016) Modulatory effects of resveratrol on endoplasmic reticulum stress-associated apoptosis and oxido-inflammatory markers in a rat model of rotenone-induced Parkinson\u2019s disease. Chemico-Biol Interact 251:10\u201316. https:\/\/doi.org\/10.1016\/j.fct.2020.111644","journal-title":"Chemico-Biol Interact"},{"issue":"8","key":"1552_CR23","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1016\/j.bbadis.2013.12.011","volume":"1842","author":"L Gan","year":"2014","unstructured":"Gan L, Johnson JA (2014) Oxidative damage and the Nrf2-ARE pathway in neurodegenerative diseases. Biochimica et Biophysica Acta (BBA)-Molecular. Basis Disease 1842(8):1208\u20131218. https:\/\/doi.org\/10.1016\/j.bbadis.2013.12.011","journal-title":"Basis Disease"},{"key":"1552_CR24","doi-asserted-by":"publisher","first-page":"885500","DOI":"10.3389\/fnagi.2022.885500","volume":"14","author":"XY Gao","year":"2022","unstructured":"Gao XY, Yang T, Gu Y, Sun XH (2022) Mitochondrial dysfunction in Parkinson\u2019s disease: from mechanistic insights to therapy. Front Aging Neurosci 14:885500. https:\/\/doi.org\/10.3389\/fnagi.2022.885500","journal-title":"Front Aging Neurosci"},{"issue":"2","key":"1552_CR25","doi-asserted-by":"publisher","first-page":"159","DOI":"10.3109\/10715762.2013.857019","volume":"48","author":"E Garc\u00eda","year":"2014","unstructured":"Garc\u00eda E, Santana-Mart\u00ednez R, Silva-Islas CA, Col\u00edn-Gonz\u00e1lez AL, Galv\u00e1n-Arzate S, Heras Y, Maldonado PD, Sotelo J, Santamar\u00eda A (2014) S-allyl cysteine protects against MPTP-induced striatal and nigral oxidative neurotoxicity in mice: participation of Nrf2. Free Radic Res 48(2):159\u2013167. https:\/\/doi.org\/10.3109\/10715762.2013.857019","journal-title":"Free Radic Res"},{"issue":"4","key":"1552_CR26","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/s41580-020-0210-7","volume":"21","author":"M Giacomello","year":"2020","unstructured":"Giacomello M, Pyakurel A, Glytsou C, Scorrano L (2020) The cell biology of mitochondrial membrane dynamics. Nat Rev Mol Cell Biol 21(4):204\u2013224. https:\/\/doi.org\/10.1038\/s41580-020-0210-7","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1552_CR27","doi-asserted-by":"publisher","unstructured":"Gnaiger E (2020) Mitochondrial pathways and respiratory control: an introduction to OXPHOS analysis. Bioenerg Commun 2020:2\u20132. https:\/\/doi.org\/10.26124\/bec:2020-0002","DOI":"10.26124\/bec:2020-0002"},{"issue":"21","key":"1552_CR28","doi-asserted-by":"publisher","first-page":"9424","DOI":"10.18632\/aging.102394","volume":"11","author":"C Guo","year":"2019","unstructured":"Guo C, Zhu J, Wang J, Duan J, Ma S, Yin Y, Quan W, Zhang W, Guan Y, Ding Y, Wen A (2019) Neuroprotective effects of protocatechuic aldehyde through PLK2\/p-GSK3\u03b2\/Nrf2 signaling pathway in both in vivo and in vitro models of Parkinson\u2019s disease. Aging 11(21):9424. https:\/\/doi.org\/10.18632\/aging.102394","journal-title":"Aging"},{"issue":"10","key":"1552_CR29","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1007\/s11064-018-02711-2","volume":"44","author":"AP Gureev","year":"2019","unstructured":"Gureev AP, Popov VN (2019) Nrf2\/ARE pathway as a therapeutic target for the treatment of Parkinson diseases. Neurochem Res 44(10):2273\u20132279. https:\/\/doi.org\/10.1007\/s11064-018-02711-2","journal-title":"Neurochem Res"},{"key":"1552_CR30","doi-asserted-by":"publisher","first-page":"101824","DOI":"10.1016\/j.mito.2023.11.007","volume":"74","author":"R Jain","year":"2024","unstructured":"Jain R, Begum N, Rajan S, Tryphena KP, Khatri DK (2024) Role of F-actin-mediated endocytosis and exercise in mitochondrial transplantation in an experimental Parkinson\u2019s disease mouse model. Mitochondrion 74:101824. https:\/\/doi.org\/10.1016\/j.mito.2023.11.007","journal-title":"Mitochondrion"},{"issue":"13","key":"1552_CR31","doi-asserted-by":"publisher","first-page":"2316","DOI":"10.1002\/mds.23926","volume":"26","author":"P Jenner","year":"2011","unstructured":"Jenner P, Langston JW (2011) Explaining ADAGIO: a critical review of the biological basis for the clinical effects of rasagiline. Mov Disord 26(13):2316\u20132323. https:\/\/doi.org\/10.1002\/mds.23926","journal-title":"Mov Disord"},{"issue":"Suppl 1","key":"1552_CR32","doi-asserted-by":"publisher","first-page":"S217","DOI":"10.33549\/physiolres.935269","volume":"73","author":"P Je\u017eek","year":"2024","unstructured":"Je\u017eek P, Dlaskov\u00e1 A, Engstov\u00e1 H, \u0160pa\u010dkov\u00e1 J, Tauber J, Pr\u016fchov\u00e1 P, Kloppel E, Mozheitova O, Jab\u016frek M (2024) Mitochondrial physiology of Cellular Redox regulations. Physiol Res 73(Suppl 1):S217. https:\/\/doi.org\/10.33549\/physiolres.935269","journal-title":"Physiol Res"},{"key":"1552_CR33","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.freeradbiomed.2015.07.147","volume":"88","author":"DA Johnson","year":"2015","unstructured":"Johnson DA, Johnson JA (2015) Nrf2\u2014a therapeutic target for the treatment of neurodegenerative diseases. Free Radic Biol Med 88:253\u2013267. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2015.07.147","journal-title":"Free Radic Biol Med"},{"issue":"7","key":"1552_CR34","doi-asserted-by":"publisher","first-page":"617","DOI":"10.3390\/antiox9070617","volume":"9","author":"TC Kang","year":"2020","unstructured":"Kang TC (2020) Nuclear factor-erythroid 2-related factor 2 (Nrf2) and mitochondrial dynamics\/mitophagy in neurological diseases. Antioxidants 9(7):617. https:\/\/doi.org\/10.3390\/antiox9070617","journal-title":"Antioxidants"},{"key":"1552_CR35","doi-asserted-by":"publisher","first-page":"115496","DOI":"10.1016\/j.bcp.2023.115496","volume":"210","author":"SS Khan","year":"2023","unstructured":"Khan SS, Janrao S, Srivastava S, Singh SB, Vora L, Khatri DK (2023) GSK-3\u03b2: an exuberating neuroinflammatory mediator in Parkinson\u2019s disease. Biochem Pharmacol 210:115496. https:\/\/doi.org\/10.1016\/j.bcp.2023.115496","journal-title":"Biochem Pharmacol"},{"key":"1552_CR36","doi-asserted-by":"publisher","first-page":"148462","DOI":"10.1016\/j.brainres.2023.148462","volume":"1815","author":"M Khot","year":"2023","unstructured":"Khot M, Sood A, Tryphena KP, Pinjala P, Srivastava S, Singh SB, Khatri DK (2023) Dimethyl fumarate ameliorates parkinsonian pathology by modulating autophagy and apoptosis via Nrf2-TIGAR-LAMP2\/Cathepsin D axis. Brain Res 1815:148462. https:\/\/doi.org\/10.1016\/j.brainres.2023.148462","journal-title":"Brain Res"},{"issue":"8","key":"1552_CR37","doi-asserted-by":"publisher","first-page":"10478","DOI":"10.3390\/ijms130810478","volume":"13","author":"H Kumar","year":"2012","unstructured":"Kumar H, Lim HW, More SV, Kim BW, Koppula S, Kim IS, Choi DK (2012) The role of free radicals in the aging brain and Parkinson\u2019s disease: convergence and parallelism. Int J Mol Sci 13(8):10478\u201310504. https:\/\/doi.org\/10.3390\/ijms130810478","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1552_CR38","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s40035-020-00221-2","volume":"9","author":"HS Kwon","year":"2020","unstructured":"Kwon HS, Koh SH (2020) Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes. Translational Neurodegeneration 9(1):42. https:\/\/doi.org\/10.1186\/s40035-020-00221-2","journal-title":"Translational Neurodegeneration"},{"key":"1552_CR39","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1007\/s12272-019-01133-0","volume":"42","author":"Y Lee","year":"2019","unstructured":"Lee Y, Lee S, Chang SC, Lee J (2019) Significant roles of neuroinflammation in Parkinson\u2019s disease: therapeutic targets for PD prevention. Arch Pharm Res 42:416\u2013425. https:\/\/doi.org\/10.1007\/s12272-019-01133-0","journal-title":"Arch Pharm Res"},{"key":"1552_CR40","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.conb.2020.10.012","volume":"67","author":"TN Lerner","year":"2021","unstructured":"Lerner TN, Holloway AL, Seiler JL (2021) Dopamine, updated: reward prediction error and beyond. Curr Opin Neurobiol 67:123\u2013130. https:\/\/doi.org\/10.1016\/j.conb.2020.10.012","journal-title":"Curr Opin Neurobiol"},{"key":"1552_CR41","doi-asserted-by":"publisher","first-page":"111644","DOI":"10.1016\/j.fct.2020.111644","volume":"144","author":"X Li","year":"2020","unstructured":"Li X, Zhang J, Zhang X, Dong M (2020) Puerarin suppresses MPP+\/MPTP-induced oxidative stress through an Nrf2-dependent mechanism. Food Chem Toxicol 144:111644. https:\/\/doi.org\/10.1016\/j.fct.2020.111644","journal-title":"Food Chem Toxicol"},{"key":"1552_CR42","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1007\/s00204-014-1","volume":"88","author":"JL Lim","year":"2014","unstructured":"Lim JL, Wilhelmus MM, de Vries HE, Drukarch B, Hoozemans JJ, van Horssen J (2014) Antioxidative defense mechanisms controlled by Nrf2: state-of-the-art and clinical perspectives in neurodegenerative diseases. Arch Toxicol 88:1773\u20131786. https:\/\/doi.org\/10.1007\/s00204-014-1","journal-title":"Arch Toxicol"},{"key":"1552_CR43","doi-asserted-by":"publisher","first-page":"878987","DOI":"10.3389\/fncel.2022.878987","volume":"16","author":"MN Lima","year":"2022","unstructured":"Lima MN, Barbosa-Silva MC, Maron-Gutierrez T (2022) Microglial priming in infections and its risk to neurodegenerative diseases. Front Cell Neurosci 16:878987. https:\/\/doi.org\/10.3389\/fncel.2022.878987","journal-title":"Front Cell Neurosci"},{"key":"1552_CR44","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.neuropharm.2013.11.026","volume":"79","author":"H Lou","year":"2014","unstructured":"Lou H, Jing X, Wei X, Shi H, Ren D, Zhang X (2014) Naringenin protects against 6-OHDA-induced neurotoxicity via activation of the Nrf2\/ARE signaling pathway. Neuropharmacology 79:380\u2013388. https:\/\/doi.org\/10.1016\/j.neuropharm.2013.11.026","journal-title":"Neuropharmacology"},{"issue":"1","key":"1552_CR45","doi-asserted-by":"publisher","first-page":"6137521","DOI":"10.1155\/2020\/6137521","volume":"2020","author":"K Ma","year":"2020","unstructured":"Ma K, Wu HY, Wang SY, Li BX (2020) Oxidative stress and neuroinflammation potentiate each other to promote progression of dopamine neurodegeneration. Oxidative Med Cell Longev 2020(1):6137521. https:\/\/doi.org\/10.1155\/2020\/6137521","journal-title":"Oxidative Med Cell Longev"},{"key":"1552_CR46","doi-asserted-by":"publisher","first-page":"112862","DOI":"10.1016\/j.ecoenv.2021.112862","volume":"226","author":"K Ma","year":"2021","unstructured":"Ma K, Wu HY, Wang SY, Li BX (2021) The Keap1\/Nrf2-ARE signaling pathway is involved in atrazine induced dopaminergic neurons degeneration via microglia activation. Ecotoxicol Environ Saf 226:112862. https:\/\/doi.org\/10.1016\/j.ecoenv.2021.112862","journal-title":"Ecotoxicol Environ Saf"},{"key":"1552_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12035-024-04417-9","volume":"7","author":"M Ma","year":"2024","unstructured":"Ma M, Jing G, Tian Y, Yin R, Zhang M (2024) Ferroptosis in Cognitive Impairment Associated with Diabetes and Alzheimer\u2019s Disease: mechanistic insights and New Therapeutic opportunities. Mol Neurobiol Aug 7:1\u20135. https:\/\/doi.org\/10.1007\/s12035-024-04417-9","journal-title":"Mol Neurobiol Aug"},{"issue":"4","key":"1552_CR48","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.tibs.2020.11.007","volume":"46","author":"AB Malpartida","year":"2021","unstructured":"Malpartida AB, Williamson M, Narendra DP, Wade-Martins R, Ryan BJ (2021) Mitochondrial dysfunction and mitophagy in Parkinson\u2019s disease: from mechanism to therapy. Trends Biochem Sci 46(4):329\u2013343. https:\/\/doi.org\/10.1016\/j.tibs.2020.11.007","journal-title":"Trends Biochem Sci"},{"key":"1552_CR49","doi-asserted-by":"publisher","first-page":"4866","DOI":"10.1007\/s12035-016-0028-7","volume":"54","author":"HE Michel","year":"2017","unstructured":"Michel HE, Tadros MG, Esmat A, Khalifa AE, Abdel-Tawab AM (2017) Tetramethylpyrazine ameliorates rotenone-induced Parkinson\u2019s disease in rats: involvement of its anti-inflammatory and anti-apoptotic actions. Mol Neurobiol 54:4866\u20134878. https:\/\/doi.org\/10.1007\/s12035-016-0028-7","journal-title":"Mol Neurobiol"},{"issue":"4","key":"1552_CR50","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1021\/acs.jafc.7b04641","volume":"66","author":"F Morroni","year":"2018","unstructured":"Morroni F, Sita G, Djemil A, D\u2019Amico M, Pruccoli L, Cantelli-Forti G, Hrelia P, Tarozzi A (2018) Comparison of adaptive neuroprotective mechanisms of sulforaphane and its interconversion product erucin in in vitro and in vivo models of Parkinson\u2019s disease. J Agric Food Chem 66(4):856\u2013865. https:\/\/doi.org\/10.1021\/acs.jafc.7b04641","journal-title":"J Agric Food Chem"},{"issue":"12","key":"1552_CR51","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.3390\/antiox11122345","volume":"11","author":"V Ngo","year":"2022","unstructured":"Ngo V, Duennwald ML (2022) Nrf2 and oxidative stress: a general overview of mechanisms and implications in human disease. Antioxidants 11(12):2345. https:\/\/doi.org\/10.3390\/antiox11122345","journal-title":"Antioxidants"},{"issue":"1","key":"1552_CR52","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1084\/jem.20180199","volume":"216","author":"GT Norris","year":"2019","unstructured":"Norris GT, Kipnis J (2019) Immune cells and CNS physiology: Microglia and beyond. J Exp Med 216(1):60\u201370. https:\/\/doi.org\/10.1084\/jem.20180199","journal-title":"J Exp Med"},{"key":"1552_CR53","doi-asserted-by":"publisher","first-page":"104651","DOI":"10.1016\/j.neubiorev.2022.104651","volume":"137","author":"PI Ortinski","year":"2022","unstructured":"Ortinski PI, Reissner KJ, Turner J, Anderson TL, Scimemi A (2022) Control of complex behavior by astrocytes and microglia. Neurosci Biobehavioral Reviews 137:104651. https:\/\/doi.org\/10.1016\/j.neubiorev.2022.104651","journal-title":"Neurosci Biobehavioral Reviews"},{"issue":"11","key":"1552_CR54","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.3390\/antiox10111649","volume":"10","author":"JA Parga","year":"2021","unstructured":"Parga JA, Rodriguez-Perez AI, Garcia-Garrote M, Rodriguez-Pallares J, Labandeira-Garcia JL (2021) NRF2 activation and downstream effects: focus on Parkinson\u2019s disease and brain angiotensin. Antioxidants 10(11):1649. https:\/\/doi.org\/10.3390\/antiox10111649","journal-title":"Antioxidants"},{"key":"1552_CR55","doi-asserted-by":"publisher","unstructured":"Pinjala P, Tryphena KP, Kulkarni A, Goswami PG, Khatri DK (2024) Dimethyl Fumarate exerts a neuroprotective effect by enhancing Mitophagy via the NRF2\/BNIP3\/PINK1 Axis in the MPP\u2009+\u2009Iodide-Induced Parkinson\u2019s Disease mice Model. J Alzheimer\u2019s Disease Rep 1329\u2013344. https:\/\/doi.org\/10.3233\/ADR-230128","DOI":"10.3233\/ADR-230128"},{"key":"1552_CR56","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s00109-013-1090-5","volume":"92","author":"P Przanowski","year":"2014","unstructured":"Przanowski P, Dabrowski M, Ellert-Miklaszewska A, Kloss M, Mieczkowski J, Kaza B, Ronowicz A, Hu F, Piotrowski A, Kettenmann H, Komorowski J (2014) The signal transducers Stat1 and Stat3 and their novel target Jmjd3 drive the expression of inflammatory genes in microglia. J Mol Med 92:239\u2013254. https:\/\/doi.org\/10.1007\/s00109-013-1090-5","journal-title":"J Mol Med"},{"key":"1552_CR57","doi-asserted-by":"publisher","first-page":"101915","DOI":"10.1016\/j.arr.2023.101915","volume":"87","author":"S Rajan","year":"2023","unstructured":"Rajan S, Tryphena KP, Khan S, Vora L, Srivastava S, Singh SB, Khatri DK (2023) Understanding the involvement of innate immunity and the Nrf2-NLRP3 axis on mitochondrial health in Parkinson\u2019s disease. Ageing Res Rev 87:101915. https:\/\/doi.org\/10.1016\/j.arr.2023.101915","journal-title":"Ageing Res Rev"},{"issue":"10","key":"1552_CR58","doi-asserted-by":"publisher","first-page":"3194","DOI":"10.3390\/molecules27103194","volume":"27","author":"A Rauf","year":"2022","unstructured":"Rauf A, Badoni H, Abu-Izneid T, Olatunde A, Rahman MM, Painuli S, Semwal P, Wilairatana P, Mubarak MS (2022) Neuroinflammatory markers: key indicators in the pathology of neurodegenerative diseases. Molecules 27(10):3194. https:\/\/doi.org\/10.3390\/molecules27103194","journal-title":"Molecules"},{"issue":"5","key":"1552_CR59","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1002\/glia.20947","volume":"58","author":"AI Rojo","year":"2010","unstructured":"Rojo AI, Innamorato NG, Mart\u00edn-Moreno AM, De Ceballos ML, Yamamoto M, Cuadrado A (2010) Nrf2 regulates microglial dynamics and neuroinflammation in experimental Parkinson\u2019s disease. Glia 58(5):588\u2013598. https:\/\/doi.org\/10.1002\/glia.20947","journal-title":"Glia"},{"issue":"22","key":"1552_CR60","doi-asserted-by":"publisher","first-page":"5474","DOI":"10.3390\/molecules25225474","volume":"25","author":"S Saha","year":"2020","unstructured":"Saha S, Buttari B, Panieri E, Profumo E, Saso L (2020) An overview of Nrf2 signaling pathway and its role in inflammation. Molecules 25(22):5474. https:\/\/doi.org\/10.3390\/molecules25225474","journal-title":"Molecules"},{"key":"1552_CR61","doi-asserted-by":"publisher","first-page":"787258","DOI":"10.3389\/fncel.2021.787258","volume":"15","author":"S Saha","year":"2022","unstructured":"Saha S, Buttari B, Profumo E, Tucci P, Saso L (2022) A perspective on Nrf2 signaling pathway for neuroinflammation: a potential therapeutic target in Alzheimer\u2019s and Parkinson\u2019s diseases. Front Cell Neurosci 15:787258. https:\/\/doi.org\/10.3389\/fncel.2021.787258","journal-title":"Front Cell Neurosci"},{"key":"1552_CR62","doi-asserted-by":"publisher","first-page":"104289","DOI":"10.1016\/j.micpath.2020.104289","volume":"147","author":"A Sengupta","year":"2020","unstructured":"Sengupta A, Mukherjee S, Ghosh S, Keswani T, Sarkar S, Majumdar G, Das M, Bhattacharyya A (2020) Partial impairment of late-stage autophagic flux in murine splenocytes leads to sqstm1\/p62 mediated nrf2-keap1 antioxidant pathway activation and induced proteasome-mediated degradation in malaria. Microb Pathog 147:104289. https:\/\/doi.org\/10.1016\/j.micpath.2020.104289","journal-title":"Microb Pathog"},{"issue":"7","key":"1552_CR63","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1080\/00207454.2016.1212854","volume":"127","author":"T Shabab","year":"2017","unstructured":"Shabab T, Khanabdali R, Moghadamtousi SZ, Kadir HA, Mohan G (2017) Neuroinflammation pathways: a general review. Int J Neurosci 127(7):624\u2013633. https:\/\/doi.org\/10.1080\/00207454.2016.1212854","journal-title":"Int J Neurosci"},{"key":"1552_CR64","doi-asserted-by":"publisher","first-page":"148954","DOI":"10.1016\/j.brainres.2024.148954","volume":"1836","author":"S Shah","year":"2024","unstructured":"Shah S, Tryphena KP, Singh G, Kulkarni A, Pinjala P, Khatri DK (2024) Neuroprotective role of Carvacrol via Nrf2\/HO-1\/NLRP3 axis in Rotenone-induced PD mice model. Brain Res 1836:148954. https:\/\/doi.org\/10.1016\/j.brainres.2024.148954","journal-title":"Brain Res"},{"key":"1552_CR65","doi-asserted-by":"publisher","first-page":"825086","DOI":"10.3389\/fnagi.2022.825086","volume":"14","author":"F Shao","year":"2022","unstructured":"Shao F, Wang X, Wu H, Wu Q, Zhang J (2022) Microglia and neuroinflammation: crucial pathological mechanisms in traumatic brain injury-induced neurodegeneration. Front Aging Neurosci 14:825086. https:\/\/doi.org\/10.3389\/fnagi.2022.825086","journal-title":"Front Aging Neurosci"},{"key":"1552_CR66","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/bs.pbr.2020.09.010","volume":"258","author":"A Sharma","year":"2020","unstructured":"Sharma A, Muresanu DF, Nozari A, Lafuente JV, Sahib S, Tian ZR, Buzoianu AD, Patnaik R, Wiklund L, Sharma HS (2020) Mild traumatic brain injury exacerbates Parkinson\u2019s disease induced hemeoxygenase-2 expression and brain pathology: neuroprotective effects of co-administration of TiO2 nanowired mesenchymal stem cells and cerebrolysin. Prog Brain Res 258:157\u2013231. https:\/\/doi.org\/10.1016\/bs.pbr.2020.09.010","journal-title":"Prog Brain Res"},{"issue":"6","key":"1552_CR67","doi-asserted-by":"publisher","first-page":"e23032","DOI":"10.1002\/jbt.23032","volume":"36","author":"B Sherkhane","year":"2022","unstructured":"Sherkhane B, Kalvala AK, Arruri VK, Khatri DK, Singh SB (2022) Renoprotective potential of myo-inositol on diabetic kidney disease: focus on the role of the PINK1\/Parkin pathway and mitophagy receptors. J Biochem Mol Toxicol 36(6):e23032. https:\/\/doi.org\/10.1002\/jbt.23032","journal-title":"J Biochem Mol Toxicol"},{"issue":"s1","key":"1552_CR68","doi-asserted-by":"publisher","first-page":"S109","DOI":"10.3233\/JAD-220793","volume":"94","author":"SM Shirgadwar","year":"2023","unstructured":"Shirgadwar SM, Kumar R, Preeti K, Khatri DK, Singh SB (2023) Neuroprotective effect of phloretin in rotenone-induced mice model of Parkinson\u2019s disease: modulating mTOR-NRF2-p62 mediated autophagy-oxidative stress crosstalk. J Alzheimers Dis 94(s1):S109\u2013S124. https:\/\/doi.org\/10.3233\/JAD-220793","journal-title":"J Alzheimers Dis"},{"issue":"6","key":"1552_CR69","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1111\/j.1471-4159.2010.07132.x","volume":"118","author":"J Sian-H\u00fclsmann","year":"2011","unstructured":"Sian-H\u00fclsmann J, Mandel S, Youdim MB, Riederer P (2011) The relevance of iron in the pathogenesis of Parkinson\u2019s disease. J Neurochem 118(6):939\u2013957. https:\/\/doi.org\/10.1111\/j.1471-4159.2010.07132.x","journal-title":"J Neurochem"},{"key":"1552_CR70","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12035-024-04474-0","volume":"4","author":"JK Sinha","year":"2024","unstructured":"Sinha JK, Jorwal K, Singh KK, Han SS, Bhaskar R, Ghosh S (2024) The potential of mitochondrial therapeutics in the treatment of oxidative stress and inflammation in aging. Mol Neurobiol Sep 4:1\u20136. https:\/\/doi.org\/10.1007\/s12035-024-04474-0","journal-title":"Mol Neurobiol Sep"},{"key":"1552_CR71","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.pneurobio.2013.04.004","volume":"106","author":"SR Subramaniam","year":"2013","unstructured":"Subramaniam SR, Chesselet MF (2013) Mitochondrial dysfunction and oxidative stress in Parkinson\u2019s disease. Prog Neurobiol 106:17\u201332. https:\/\/doi.org\/10.1016\/j.pneurobio.2013.04.004","journal-title":"Prog Neurobiol"},{"issue":"9","key":"1552_CR72","doi-asserted-by":"publisher","first-page":"2460","DOI":"10.1093\/brain\/awx172","volume":"140","author":"J Tong","year":"2017","unstructured":"Tong J, Rathitharan G, Meyer JH, Furukawa Y, Ang LC, Boileau I, Guttman M, Hornykiewicz O, Kish SJ (2017) Brain monoamine oxidase B and A in human parkinsonian dopamine deficiency disorders. Brain 140(9):2460\u20132474. https:\/\/doi.org\/10.1093\/brain\/awx172","journal-title":"Brain"},{"issue":"1","key":"1552_CR73","doi-asserted-by":"publisher","first-page":"314082","DOI":"10.4061\/2011\/314082","volume":"2011","author":"KU Tufekci","year":"2011","unstructured":"Tufekci KU, Civi Bayin E, Genc S, Genc K (2011) The Nrf2\/ARE pathway: a promising target to counteract mitochondrial dysfunction in Parkinson\u2032 s disease. Parkinson\u2019s Disease 2011(1):314082. https:\/\/doi.org\/10.4061\/2011\/314082","journal-title":"Parkinson\u2019s Disease"},{"issue":"7","key":"1552_CR74","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.3390\/antiox10071069","volume":"10","author":"F Villavicencio Tejo","year":"2021","unstructured":"Villavicencio Tejo F, Quintanilla RA (2021) Contribution of the Nrf2 pathway on oxidative damage and mitochondrial failure in Parkinson and Alzheimer\u2019s disease. Antioxidants 10(7):1069. https:\/\/doi.org\/10.3390\/antiox10071069","journal-title":"Antioxidants"},{"key":"1552_CR75","doi-asserted-by":"publisher","unstructured":"Vomund S, Sch\u00e4fer A, Parnham MJ, Br\u00fcne B, Von Knethen A (2015) Nrf2 regulates ROS production by mitochondria and NADPH oxidase. Biochimica et Biophysica Acta (BBA)-General subjects. 1850(4):794\u2013801. https:\/\/doi.org\/10.1016\/j.bbagen.2014.11.021","DOI":"10.1016\/j.bbagen.2014.11.021"},{"issue":"12","key":"1552_CR76","doi-asserted-by":"publisher","first-page":"2772","DOI":"10.3390\/ijms18122772","volume":"18","author":"S Vomund","year":"2017","unstructured":"Vomund S, Sch\u00e4fer A, Parnham MJ, Br\u00fcne B, Von Knethen A (2017) Nrf2, the master regulator of anti-oxidative responses. Int J Mol Sci 18(12):2772. https:\/\/doi.org\/10.3390\/ijms18122772","journal-title":"Int J Mol Sci"},{"issue":"2","key":"1552_CR77","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.lfs.2014.08.004","volume":"114","author":"XL Wang","year":"2014","unstructured":"Wang XL, Xing GH, Hong B, Li XM, Zou Y, Zhang XJ, Dong MX (2014) Gastrodin prevents motor deficits and oxidative stress in the MPTP mouse model of Parkinson\u2019s disease: involvement of ERK1\/2\u2013Nrf2 signaling pathway. Life Sci 114(2):77\u201385. https:\/\/doi.org\/10.1016\/j.lfs.2014.08.004","journal-title":"Life Sci"},{"key":"1552_CR78","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40035-015-0042-0","volume":"4","author":"Q Wang","year":"2015","unstructured":"Wang Q, Liu Y, Zhou J (2015) Neuroinflammation in Parkinson\u2019s disease and its potential as therapeutic target. Translational Neurodegeneration 4:1\u20139. https:\/\/doi.org\/10.1186\/s40035-015-0042-0","journal-title":"Translational Neurodegeneration"},{"key":"1552_CR79","doi-asserted-by":"publisher","first-page":"757161","DOI":"10.3389\/fphar.2021.757161","volume":"12","author":"Y Wang","year":"2021","unstructured":"Wang Y, Gao L, Chen J, Li Q, Huo L, Wang Y, Wang H, Du J (2021) Pharmacological modulation of Nrf2\/HO-1 signaling pathway as a therapeutic target of Parkinson\u2019s disease. Front Pharmacol 12:757161. https:\/\/doi.org\/10.3389\/fphar.2021.757161","journal-title":"Front Pharmacol"},{"key":"1552_CR80","doi-asserted-by":"publisher","first-page":"105651","DOI":"10.1016\/j.intimp.2019.05.036","volume":"75","author":"C Yang","year":"2019","unstructured":"Yang C, Mo Y, Xu E, Wen H, Wei R, Li S, Zheng J, Li W, Le B, Chen Y, Pan H (2019) Astragaloside IV ameliorates motor deficits and dopaminergic neuron degeneration via inhibiting neuroinflammation and oxidative stress in a Parkinson\u2019s disease mouse model. Int Immunopharmacol 75:105651. https:\/\/doi.org\/10.1016\/j.intimp.2019.05.036","journal-title":"Int Immunopharmacol"},{"issue":"3","key":"1552_CR81","doi-asserted-by":"publisher","first-page":"207","DOI":"10.2174\/1871527317666180425122557","volume":"17","author":"H Yaribeygi","year":"2018","unstructured":"Yaribeygi H, Panahi Y, Javadi B, Sahebkar A (2018) The underlying role of oxidative stress in neurodegeneration: a mechanistic review. CNS & neurological disorders-drug targets (formerly current drug Targets-CNS &. Neurol Disorders) 17(3):207\u2013215. https:\/\/doi.org\/10.2174\/1871527317666180425122557","journal-title":"Neurol Disorders)"},{"key":"1552_CR82","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s10534-018-0111-9","volume":"31","author":"ET Zakharova","year":"2018","unstructured":"Zakharova ET, Sokolov AV, Pavlichenko NN, Kostevich VA, Abdurasulova IN, Chechushkov AV, Voynova IV, Elizarova AY, Kolmakov NN, Bass MG, Semak IV (2018) Erythropoietin and Nrf2: key factors in the neuroprotection provided by apo-lactoferrin. Biometals 31:425\u2013443. https:\/\/doi.org\/10.1007\/s10534-018-0111-9","journal-title":"Biometals"},{"issue":"5","key":"1552_CR83","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1038\/labinvest.2015.161","volume":"96","author":"XF Zhang","year":"2016","unstructured":"Zhang XF, Thompson M, Xu YH (2016) Multifactorial theory applied to the neurotoxicity of paraquat and paraquat-induced mechanisms of developing Parkinson\u2019s disease. Lab Invest 96(5):496\u2013507. https:\/\/doi.org\/10.1038\/labinvest.2015.161","journal-title":"Lab Invest"},{"key":"1552_CR84","doi-asserted-by":"publisher","unstructured":"Zhong Y, Cai X, Ding L, Liao J, Liu X, Huang Y, Chen X, Long L (2022) Nrf2 inhibits the progression of Parkinson\u2019s disease by upregulating AABR07032261. 5 to repress pyroptosis. J Inflamm Res 669\u2013685. https:\/\/doi.org\/10.2147\/JIR.S345895","DOI":"10.2147\/JIR.S345895"}],"container-title":["Metabolic Brain Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-025-01552-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11011-025-01552-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-025-01552-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T04:06:13Z","timestamp":1740801973000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11011-025-01552-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,11]]},"references-count":84,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,2]]}},"alternative-id":["1552"],"URL":"https:\/\/doi.org\/10.1007\/s11011-025-01552-7","relation":{},"ISSN":["1573-7365"],"issn-type":[{"value":"1573-7365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,11]]},"assertion":[{"value":"7 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"123"}}